| # | Drug | Count |
|---|---|---|
| 0 | CYCLOSPORINE | 4 |
| 1 | HYDROCHLOROTHIAZIDE | 4 |
| 2 | TACROLIMUS | 4 |
| 3 | AZITHROMYCIN | 3 |
| 4 | AZITHROMYCIN DIHYDRATE | 3 |
| 5 | AZITHROMYCIN MONOHYDRATE | 3 |
| 6 | PREDNISOLONE | 3 |
| 7 | PREDNISOLONE ORAL | 3 |
| 8 | PREDNISOLONE ORAL SOLUTION | 3 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MILTEFOSINE | 1 | 0.0026 |
| 1 | LISOCABTAGENE MARALEUCEL | 1 | 0.0011 |
| 2 | CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | 1 | 0.0005 |
| 3 | EFINACONAZOLE | 1 | 0.0005 |
| 4 | ZICONOTIDE ACETATE | 1 | 0.0004 |
| 5 | COLESTIPOL HYDROCHLORIDE | 1 | 0.0004 |
| 6 | IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE | 1 | 0.0002 |
| 7 | AMPHOTERICIN B | 1 | 0.0001 |
| 8 | REMDESIVIR | 1 | 0.0001 |
| 9 | AZITHROMYCIN MONOHYDRATE | 3 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Calcineurin Inhibitor Immunosuppressant [EPC] | 4 |
| 1 | Thiazide Diuretic [EPC] | 4 |
| 2 | Corticosteroid [EPC] | 3 |
| 3 | Aminosalicylate [EPC] | 2 |
| 4 | Alkylating Drug [EPC] | 1 |
| 5 | Anti-IgE [EPC] | 1 |
| 6 | Antileishmanial [EPC] | 1 |
| 7 | Azole Antifungal [EPC] | 1 |
| 8 | Benzodiazepine [EPC] | 1 |
| 9 | Expectorant [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antileishmanial [EPC] | 1 | 0.0026 |
| 1 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 2 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 3 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 4 | Calcineurin Inhibitor Immunosuppressant [EPC] | 4 | 0.0000 |
| 5 | Polyene Antifungal [EPC] | 1 | 0.0000 |
| 6 | Aminosalicylate [EPC] | 2 | 0.0000 |
| 7 | Thiazide Diuretic [EPC] | 4 | 0.0000 |
| 8 | Anti-IgE [EPC] | 1 | 0.0000 |
| 9 | Azole Antifungal [EPC] | 1 | 0.0000 |